Oregon HA Health Evidence Review Commission Report Acellular Scaffold Implant March 2026
CartiHeal Agili-C implant profiled in HERC report
Trusted by teams at
Description
The Oregon Health Evidence Review Commission report profiles CartiHeal's Agili-C acellular scaffold implant for knee cartilage lesions, noting its FDA approvals and clinical evidence base. No specific purchase or contracting action related to this product is recorded in the document.
Contract Details
Vendor
CARTIHEAL
Agency
Oregon HA | Health Evidence Review Commission, OR
Contract Type
EQUIPMENT
Document Date
March 17, 2026
More from Oregon HA | Health Evidence Review Commission
Oregon Health Authority Public Comments March 2026
Health Evidence Review Commission and Value-based Benefits Subcommittee Meeting Agenda March 19, 2026
Health Evidence Review Commission and Value-based Benefits Subcommittee Meeting Agenda March 19, 2026
Health Evidence Review Commission and Value-based Benefits Subcommittee Meeting Agenda March 19, 2026
Health Evidence Review Commission and Value-based Benefits Subcommittee Meeting Agenda March 19, 2026
Want to learn more?
Get alerts on contract renewals, new awards, and vendor activity.
Bring us your territory.
We'll show you what is forming.
See live SLED buying signals, source docs, decision-makers, contract context, and the next step into your CRM or pipeline.